对轴性脊椎关节炎的运动处方:随机对照试验的系统审查和元分析
Chunhui Yu1, Lina Guo2, Xiaoxiao Gao3
1The First Clinical College, Liaoning University of Traditional Chinese Medicine, Shenyang, China.
Frontiers in medicine
|March 9, 2026
概括
运动疗法显著改善疾病活动,身体功能,脊柱运动性和轴性脊柱关节炎 (axSpA) 患者的疲劳. 这一元分析支持个性化的运动处方作为axSp.A.的关键治疗组件.
科学领域:
- 类风湿病学 类风湿病学
- 运动科学 运动科学
- 临床研究 临床研究
背景情况:
- 轴性脊椎关节炎 (axSpA) 是一种慢性炎症状况,影响生活质量.
- 运动疗法是对axSpA的关键非药物治疗方法.
- 对axSpA的运动有效性和最佳参数的证据需要进一步进行高质量的研究.
研究的目的:
- 系统地评估 axSpA.患者的运动干预措施的有效性.
- 为临床实践提供基于证据的指导,关于 axSpA.运动的临床实践.
- 为了确定axSpA管理的最佳运动处方参数.
主要方法:
- 在PubMed,Embase,Web of Science和Cochrane图书馆进行系统的文献搜索,截至2025年9月.
- 包括随机对照试验 (RCT),比较运动干预措施与 axSpA.的常规治疗方法.
- 使用Stata 15.0进行元分析,评估I平方统计数据的异质性,并以95%的置信区间呈现结果.
主要成果:
- 有1699名患者的15个RCT显示,运动干预显著改善.
- 运动改善了疾病活动 (BASDAI,ASDAS),身体功能 (BASFI),脊柱运动 (BASMI),胸部扩张和减少疲劳.
- 亚组分析表明,运动方式和持续时间影响了治疗疗效.
结论:
- 运动干预措施显著提高axSpA患者的核心结果指标.
- 个性化的运动处方应纳入标准的axSpA治疗方案.
- 需要进一步的研究来优化炼参数并确认长期疗效.
更多相关视频
04:50Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
1.2K
07:01Clinical Efficacy of Ultrasound-Assisted Scoliosis-Specific Exercise in Mild-Grade Adolescent Idiopathic Scoliosis
Published on: December 2, 2025
394
相关概念视频
Rheumatic Heart Disease III: Medical Management
544
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
544
Atherosclerosis III: Management
741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
